Trial of dual therapy using esomeprazole and amoxicillin as third-line rescue therapy for Helicobacter pylori infection

被引：0
|
作者：
Park, H. K. [1 ]
Suh, S. C. [1 ]
Seo, P. J. [1 ]
Shin, C. M. [1 ]
Kim, N. Y. [1 ]
Lee, D. H. [1 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, Gyeonggi Do, South Korea
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2011年 / 26卷
关键词：
Helicobacter pylori; therapy; proton pump inhibitor; amoxicillin;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：267 / 267
页数：1
相关论文
共 50 条
  • [21] Helicobacter pylori eradication rate of levofloxacin-based therapy as third-line therapy
    Kang, M.
    Lee, S.
    Goo, E.
    Kim, K.
    Jang, B.
    Yang, C.
    [J]. HELICOBACTER, 2017, 22
  • [22] Sitafloxacin-based third-line rescue regimens for Helicobacter pylori infection in Japan
    Furuta, Takahisa
    Sugimoto, Mitsushige
    Kodaira, Chise
    Nishino, Masafumi
    Yamade, Mihoko
    Uotani, Takahiro
    Sahara, Shu
    Ichikawa, Hitomi
    Yamada, Takanori
    Osawa, Satoshi
    Sugimoto, Ken
    Watanabe, Hiroshi
    Umemura, Kazuo
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (03) : 487 - 493
  • [23] Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication
    Nishizawa, Toshihiro
    Suzuki, Hidekazu
    Hibi, Toshifumi
    [J]. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2009, 44 (02) : 119 - 124
  • [24] EFFICACY OF RIFABUTIN BASED TRIPLE THERAPY INCLUDING HIGH DOSE PPI AND AMOXICILLIN FOR THIRD LINE RESCUE THERAPY OF HELICOBACTER PYLORI
    Moon, B. S.
    Lim, H. C.
    Lee, Y. C.
    Hahn, K. H.
    Jung, J. B.
    Cheon, C. Y.
    Lee, S. I.
    [J]. HELICOBACTER, 2012, 17 : 105 - 105
  • [25] Efficacy and safety of high-dose esomeprazole-amoxicillin dual therapy for Helicobacter pylori rescue treatment: a multicenter, prospective, randomized, controlled trial
    Bi, Hanxin
    Chen, Xingxing
    Chen, Yuxin
    Zhao, Xin
    Wang, Shasha
    Wang, Jiehong
    Lyu, Ting
    Han, Shuang
    Lin, Tao
    Li, Mingquan
    Yuan, Donghong
    Liu, Junye
    Shi, Yongquan
    [J]. CHINESE MEDICAL JOURNAL, 2022, 135 (14) : 1707 - 1715
  • [26] Letter: third-line rescue therapy with levofloxacin after failure of two treatments to eradicate Helicobacter pylori infection - author's reply
    Goh, K. -L.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (12) : 1486 - 1486
  • [27] Eradication rate according to duration of third-line rescue therapy with levofloxacin after Helicobacter pylori treatment failure
    Kim, H.
    Hong, S.
    Goong, H.
    Kim, H.
    Jung, H.
    Lee, T.
    Lee, J.
    [J]. HELICOBACTER, 2016, 21 : 153 - 153
  • [28] Sequential therapy using high dose esomeprazole-amoxicillin followed by gatifloxacin for primary or salvage therapy for Helicobacter pylori infection
    Graham, D. Y.
    Abudayyeh, S.
    El-Zimaity, H. M. T.
    Hoffman, J.
    Reddy, R.
    Opekun, A. R.
    [J]. HELICOBACTER, 2006, 11 : 38 - 38
  • [29] LEVOFLOXACIN SEQUENTIAL THERAPY VERSUS BISMUTH QUADRUPLE THERAPY IN THE SECOND-LINE AND THIRD-LINE TREATMENT OF HELICOBACTER PYLORI INFECTION- A MULTICENTER RANDOMIZED TRIAL
    Liou, Jyh-Ming
    Chen, Chieh-Chang
    Fang, Yu-Jen
    Chen, Po-Yueh
    Lin, Jaw-Town
    Wu, Ming-Shiang
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S570 - S570
  • [30] Randomized Trial on 14 versus 7 days of Esomeprazole, Moxifloxacin, and Amoxicillin for Second-line or Rescue Treatment of Helicobacter pylori Infection
    Miehlke, Stephan
    Krasz, Susanne
    Schneider-Brachert, Wulf
    Kuhlisch, Eberhard
    Berning, Marco
    Madisch, Ahmed
    Laass, Martin W.
    Neumeyer, Michael
    Jebens, Claus
    Zekorn, Christian
    Knoth, Holger
    Vieth, Michael
    Stolte, Manfred
    Lehn, Norbert
    Morgner, Andrea
    [J]. HELICOBACTER, 2011, 16 (06) : 420 - 426
12345